Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Is FAST-Forward/ultra-hypofractionation suitable for an early-stage breast patient after a lumpectomy with oncoplastic reduction?
Answer from: Radiation Oncologist at Community Practice
Yes, FAST-Forward is fine after oncoplastic reduction as long as dose homogeneity criteria can be met (V105 < 5%).
Comments
Radiation Oncologist at Indiana University Health
@Sushil Beriwal, is there any thought that if a pa...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
As long as dosimetric and clinical criteria are me...
15540
15544
Sign In
or
Register
to read more
26566
Related Questions
Would you forgo lumpectomy cavity boost for grade 1 papillary carcinoma with associated grade 1 DCIS that has been resected with good margins?
What are your top takeaways in Breast Cancer from ASCO 2025?
What is the maximum dose that you would give to residual unresectable gross disease in the axilla in the setting of recurrent breast cancer s/p ALND?
How do you optimally set a patient up for breast radiation therapy if you don't have access to a breast board or wing board?
When do you start adjuvant radiation with areas of delayed wound healing after reduction mammoplasty?
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?
What is your preferred comprehensive nodal irradiation approach in non-metastatic breast cancer patients with underlying respiratory diseases or poor baseline respiratory function in light of the findings from the RadComp Trial?
Would you offer partial breast radiation to a young breast cancer patient with BRCA 1 if all other criteria are met?
In what patients is it inappropriate to offer DCISionRT testing?
Would you recommend PMRT to a clinically node positive (biopsy proven axillary node and indeterminate single IMN node) BRCA positive patient with multiple medical co-morbidities including scleroderma and ILD who is treated with neoadjuvant chemotherapy (NAC) and mastectomy who converts to ypT0/ypN0?
@Sushil Beriwal, is there any thought that if a pa...
As long as dosimetric and clinical criteria are me...